Exact Mass: 704.5532012
Exact Mass Matches: 704.5532012
Found 500 metabolites which its exact mass value is equals to given mass value 704.5532012,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
SM(d18:0/16:0)
Sphingomyelin (d18:0/16:0) or SM(d18:0/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:0/16:0) consists of a sphinganine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:0/16:0) or SM(d18:0/16:0)is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(18:0/16:0) consists of stearic acid attached to the C1 position and palmitic acid attached to the C2 position. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.
PA(14:0/22:0)
PA(14:0/22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/22:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of behenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(16:0/20:0)
PA(16:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/20:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(20:0/16:0)
PA(20:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(21:0/15:0)
PA(21:0/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(21:0/15:0), in particular, consists of one chain of heneicosylic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(22:0/14:0)
PA(22:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(20:0/i-16:0)
PA(20:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/i-16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(21:0/a-15:0)
PA(21:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(21:0/a-15:0), in particular, consists of one chain of heneicosylic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(21:0/i-15:0)
PA(21:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(21:0/i-15:0), in particular, consists of one chain of heneicosylic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(22:0/i-14:0)
PA(22:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/i-14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-21:0/15:0)
PA(a-21:0/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-21:0/15:0), in particular, consists of one chain of anteisoheneicosanoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-21:0/a-15:0)
PA(a-21:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-21:0/a-15:0), in particular, consists of one chain of anteisoheneicosanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-21:0/i-15:0)
PA(a-21:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-21:0/i-15:0), in particular, consists of one chain of anteisoheneicosanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-24:0)
PA(i-12:0/i-24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-24:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isotetracosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-20:0/16:0)
PA(i-20:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/16:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-20:0/i-16:0)
PA(i-20:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/i-16:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-21:0/15:0)
PA(i-21:0/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-21:0/15:0), in particular, consists of one chain of isoheneicosanoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-21:0/a-15:0)
PA(i-21:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-21:0/a-15:0), in particular, consists of one chain of isoheneicosanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-21:0/i-15:0)
PA(i-21:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-21:0/i-15:0), in particular, consists of one chain of isoheneicosanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-22:0/14:0)
PA(i-22:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-22:0/14:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-22:0/i-14:0)
PA(i-22:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-22:0/i-14:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-24:0/12:0)
PA(i-24:0/12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-24:0/12:0), in particular, consists of one chain of isotetracosanoic acid at the C-1 position and one chain of lauric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-24:0/i-12:0)
PA(i-24:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-24:0/i-12:0), in particular, consists of one chain of isotetracosanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
CE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
CE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
CE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
CE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
CE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
CE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.
DG(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(20:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/20:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(20:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/20:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
DG(20:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/20:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(i-20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-20:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(i-20:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-20:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(i-20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-20:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(i-20:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-20:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(i-20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-20:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
DG(i-20:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-20:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Flavuxanthin
A C50 carotenoid that is an intermediate in the biosyntheses of decaprenoxanthin by Corynebacterium glutamicum and gamma-cyclic sarcinaxanthin by Micrococcus luteus.
Sarcinaxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
C.p. 473
Bisanhydrobacterioruberin
A C50 carotenoid that is an intermediate in the biosynthesis of bacterioruberin, a red-coloured pigment found in several Halobacterium and Haloarcula species.
A.g.571
2-(Dihydroxy-isopentenyl)-2-isopentenyl-beta-carotin
Decaprenoxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
C.p.473
[2-octadecanoyloxy-3-phosphonooxypropyl] octadecanoate
(2-{[2-hexadecanamido-3-hydroxyoctadecyl phosphono]oxy}ethyl)trimethylazanium
Cholesteryl 11-hydroperoxy-eicosatetraenoate
A.g.471
1-[(Phosphonooxy)methyl]ethane-1,2-diyl distearate
[2-(Hexadecanoylamino)-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate
(2R,6R,2R,6R)-decaprenoxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
2,2-Bis-(4-hydroxy-3-methybut-2-enyl)-beta,beta-carotene
2-(4-Hydroxy-3-methylbut-2-enyl)-2-(3-methylbut-2-enyl)-3,4-didehydro-1,2-dihydro-beta,psi-caroten-1-ol
2-[[(2R)-3-[(Z)-hexadec-1-enoxy]-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-[(Z)-hexadec-1-enoxy]-3-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
N-(eicosanoyl)-tetradecasphinganine-1-phosphocholine
N-(2-hydroxyhexadecanoyl)-15-methylhexadecasphing-4-enine-1-phosphocholine
[3-Hydroxy-2-(octanoylamino)hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[3-Hydroxy-2-(nonanoylamino)pentacosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate
[1-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[1-hydroxy-3-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoxy]-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(2-Acetamido-3-hydroxydotriacontyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxyoctacosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate
[1-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[3-Hydroxy-2-(pentacosanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxyheptacosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate
[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate
[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[2-(Butanoylamino)-3-hydroxytriacontyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)hentriacontyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate
[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoate
[1-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate
[3-Hydroxy-2-(pentanoylamino)nonacosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[3-Hydroxy-2-(tetracosanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate
4-[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
[3-Hydroxy-2-(tricosanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Docosanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Henicosanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxytetracosyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoate
[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate
[2-(Hexacosanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(icosanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(nonadecanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octadecanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptadecanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentadecanoylamino)nonadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tetradecanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tridecanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Dodecanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) heptacosanoate
(1-Heptadecanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Pentadecanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate
(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) docosanoate
(1-Hexadecanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) hexacosanoate
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) pentacosanoate
(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate
(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) tricosanoate
[3,4-dihydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3,4-dihydroxy-2-(pentadecanoylamino)octadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
N-(pentadecanoyl)-nonadecasphinganine-1-phosphocholine
N-(tetradecanoyl)-eicosasphinganine-1-phosphocholine
N-(heptadecanoyl)-heptadecasphinganine-1-phosphocholine
N-(nonadecanoyl)-pentadecasphinganine-1-phosphocholine
[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-decanoyloxy-2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] tetracosanoate
[1-carboxy-3-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(10E,12E)-octadeca-10,12-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-hexadecanoyloxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[hydroxy-[(2S)-3-[(E)-icos-1-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(14E,16E)-docosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] pentacosanoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] hexacosanoate
[1-carboxy-3-[3-hexadecanoyloxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R,3S)-2-(dodecanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-carboxy-3-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-dodecanoyloxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-tetradecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] tetracosanoate
[1-carboxy-3-[2-[(10E,12E)-octadeca-10,12-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(E)-heptadec-7-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-tridecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[hydroxy-[(2S)-3-[(E)-octadec-1-enoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[3-dodecanoyloxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(E)-octadec-11-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R,3S)-3-hydroxy-2-(tridecanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] tricosanoate
[1-carboxy-3-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(E)-octadec-11-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-tridecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(14E,16E)-docosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(E)-heptadec-7-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[3-[2,3-bis[[(4E,7E)-hexadeca-4,7-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] hexacosanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] pentacosanoate
[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] tricosanoate
[1-carboxy-3-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-decanoyloxy-3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[(2R)-3-[(E)-hexadec-1-enoxy]-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-tetradecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-decanoyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[3-octanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-tetradecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[3-[2,3-bis[[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[3-[(Z)-hexadec-9-enoxy]-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[3-dodecanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[2-heptadecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[3-hexadecanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[3-hexadecoxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[hydroxy-[3-octadecoxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
[1-carboxy-3-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
[1-carboxy-3-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-tetradecanoyloxypropoxy]propyl]-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[2-[(Z)-docos-13-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[carboxy-[3-[(17Z,20Z,23Z,26Z,29Z)-dotriaconta-17,20,23,26,29-pentaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium
C42H74NO7+ (704.5464993999999)
2-[[3-[(Z)-hexacos-15-enoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[3-[(Z)-heptadec-9-enoxy]-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-pentadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-heptanoyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-hexadecanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[3-[(Z)-octacos-17-enoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[2-octadecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[3-dodecoxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-decanoyloxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[3-heptadecoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[3-[(Z)-docos-13-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[3-[(Z)-icos-11-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[3-decoxy-2-[(Z)-henicos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[[2-dodecanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C39H79NO7P+ (704.5593853999999)
1-heneicosanoyl-2-pentadecanoyl-glycero-3-phosphate
[(2R)-2-(13-methyltetradecanoyloxy)-3-phosphonooxypropyl] henicosanoate
1,2-dioctadecanoyl-sn-glycerol-3-phosphate
A 1-acyl-2-octadecanoyl-sn-glycerol-3-phosphate in which the 1-acyl group is also octadecanoyl.
N-hexadecanoylsphinganine-1-phosphocholine
A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and sphinganine respectively.
PMe(36:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PMe(35:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PEt(34:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(43:9)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePA(34:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved